SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-009770
Filing Date
2022-06-07
Accepted
2022-06-07 16:05:22
Documents
13
Period of Report
2022-06-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K tmbr-20220607x8k.htm   iXBRL 8-K 64343
  Complete submission text file 0001558370-22-009770.txt   192376

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmbr-20220607.xsd EX-101.SCH 3729
3 EX-101.DEF tmbr-20220607_def.xml EX-101.DEF 2725
4 EX-101.LAB tmbr-20220607_lab.xml EX-101.LAB 17262
5 EX-101.PRE tmbr-20220607_pre.xml EX-101.PRE 10072
7 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20220607x8k_htm.xml XML 4812
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 221001257
SIC: 2834 Pharmaceutical Preparations